Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
RP3-340N1.2 Knockdown Destabilizes IL-6 in NSCLC Progression
2026-05-21
This study reveals that the long non-coding RNA RP3-340N1.2 sustains non-small cell lung cancer (NSCLC) progression by stabilizing IL-6 mRNA. Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation, suppressing tumor proliferation and migration, and suggests new avenues for targeting transcriptional regulation in NSCLC.
-
RP3-340N1.2 Knockdown Suppresses NSCLC via IL-6 mRNA Destabi
2026-05-21
This study identifies the lncRNA RP3-340N1.2 as a critical regulator of non-small cell lung cancer (NSCLC) progression by stabilizing IL-6 mRNA. Knockdown of RP3-340N1.2 impairs tumor proliferation and migration, offering a mechanistically grounded target for future transcriptional regulation research.
-
Difloxacin HCl: Beyond Antimicrobial Testing to Resistance M
2026-05-20
Explore how Difloxacin HCl, a quinolone antimicrobial antibiotic, advances both susceptibility testing and multidrug resistance reversal. This article delivers a unique, in-depth look at its molecular action, practical protocols, and the latest insights from checkpoint regulation research.
-
Butylated Hydroxyanisole (BHA): Advanced Redox Modulation in
2026-05-20
Explore how Butylated hydroxyanisole (BHA) enables precision control of oxidative stress and reactive oxygen species (ROS) in cutting-edge biomedical research. Discover distinctive workflow insights, critical protocol parameters, and expert guidance that extend beyond existing BHA content.
-
Indole-3-pyruvic Acid Modulates Th17/Treg Balance in RA via
2026-05-19
This study demonstrates that indole-3-pyruvic acid (IPA), a tryptophan metabolite, alleviates rheumatoid arthritis by restoring Th17/Treg cell balance through the aryl hydrocarbon receptor (AhR) pathway. These findings offer mechanistic insight into immune modulation in RA and highlight IPA as a potential research tool for investigating AhR-mediated immunoregulation.
-
Ginsenoside Rg1 Restores Gut-Immune-Brain Axis After Anesthe
2026-05-19
Ginsenoside Rg1, a triterpene saponin from Panax ginseng, was shown to reverse neuroimmune and behavioral disturbances induced by prolonged isoflurane anesthesia in mice. The study provides mechanistic evidence for regulatory T cell–mediated restoration of the gut-immune-brain axis, highlighting Rg1's translational potential in mitigating postoperative cognitive decline.
-
TUNEL Apoptosis Detection Kit (DAB): Advancing Amyloidosis a
2026-05-18
Explore how the TUNEL Apoptosis Detection Kit (DAB) empowers apoptosis and amyloidosis research through advanced DNA fragmentation detection. This article provides scientific depth, unique application insights, and evidence-backed assay guidance.
-
Norovirus Harnesses NINJ1 for Selective Viral Protein Secret
2026-05-18
This study uncovers how murine norovirus (MNoV) exploits the host membrane protein NINJ1 to specifically secrete its NS1 protein, revealing a novel, regulated mechanism of unconventional protein secretion during infection. The findings redefine our understanding of cell death and host–pathogen interactions, with implications for broader research in regulated protein release.
-
Oligo (dT) 25 Beads: Streamlined Superparamagnetic mRNA Isol
2026-05-17
Oligo (dT) 25 Beads deliver rapid, high-yield eukaryotic mRNA isolation using superparamagnetic technology, enabling robust downstream assays from RT-PCR to next-gen sequencing. Their precision in polyA tail mRNA capture is critical for reproducible molecular profiling in advanced cancer metabolism research.
-
Tetracycline: Broad-Spectrum Polyketide Antibiotic in ER Str
2026-05-16
Tetracycline’s utility now extends well beyond antimicrobial selection, offering precise control in advanced workflows for modeling endoplasmic reticulum (ER) stress and hepatic fibrosis. Leveraging APExBIO’s high-purity tetracycline, researchers can achieve reproducible antibiotic selection and dissect ribosomal mechanisms in translational liver research.
-
SLC1A4 Drives Hepatocellular Carcinoma via AKT Pathway Activ
2026-05-15
This study demonstrates that SLC1A4 overexpression promotes malignant transformation in hepatocellular carcinoma by activating AKT signaling, influencing proliferation, migration, and stemness of hepatic cancer cells. The findings reveal SLC1A4 as a candidate diagnostic and therapeutic target in HCC, with implications for early detection and intervention strategies.
-
Tigecycline: Applied Workflows for Combating MDR Bacteria
2026-05-15
Tigecycline, a pioneering glycylcycline antibiotic, empowers researchers with robust, reproducible workflows against multidrug-resistant bacteria. This article delivers protocol enhancements, troubleshooting strategies, and data-driven insights for maximizing experimental success in MDR and resistance transmission studies.
-
Dinaciclib Synthetic Lethality in VHL-Deficient Renal Cancer
2026-05-14
This study demonstrates that the cyclin-dependent kinase inhibitor Dinaciclib selectively induces cell death in clear cell renal cell carcinoma (CC-RCC) cells lacking the VHL tumor suppressor. Through in vitro and in vivo models, the authors establish a new vulnerability in VHL-deficient tumors, supporting Dinaciclib as a promising therapeutic for CC-RCC.
-
Pulchinenoside B4 Inhibits NLRP3 Inflammasome in DSS Colitis
2026-05-14
This study demonstrates that Pulchinenoside B4 (PB4) alleviates DSS-induced colitis in mice by targeting macrophage CD1d and suppressing NLRP3 inflammasome activation through the AKT-STAT1-PRDX1-NF-κB pathway. These findings highlight a novel mechanism for anti-inflammatory intervention in ulcerative colitis and inform future therapeutic strategies.
-
Tacrolimus (FK506): Precision Tools for Immune Pathway Resea
2026-05-13
Explore how Tacrolimus (FK506) advances immune response suppression and cytokine signaling pathway modulation in translational research. This article uncovers mechanistic nuances and strategic protocol guidance, offering unique practical insights beyond existing literature.
8570 records 14/572 page Previous Next First page 上5页 1112131415 下5页 Last page